Literature DB >> 25814677

Small HDL promotes cholesterol efflux by the ABCA1 pathway in macrophages: implications for therapies targeted to HDL.

Jay W Heinecke1.   

Abstract

Entities:  

Keywords:  Editorials; atherosclerosis; cholesterol metabolism; lipid therapy; lipoproteins; macrophage

Mesh：

Substances：

Year:  2015        PMID： 25814677      PMCID： PMC4380245          DOI： 10.1161/CIRCRESAHA.115.306052

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  13 in total

1.  HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events.

Authors:  Robert S Rosenson; H Bryan Brewer; M John Chapman; Sergio Fazio; M Mahmood Hussain; Anatol Kontush; Ronald M Krauss; James D Otvos; Alan T Remaley; Ernst J Schaefer
Journal:  Clin Chem       Date:  2011-01-25       Impact factor: 8.327

2.  The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?

Authors:  Daniel J Rader; Alan R Tall
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

3.  HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.

Authors:  Xian-Ming Du; Mi-Jurng Kim; Liming Hou; Wilfried Le Goff; M John Chapman; Miranda Van Eck; Linda K Curtiss; John R Burnett; Sian P Cartland; Carmel M Quinn; Maaike Kockx; Anatol Kontush; Kerry-Anne Rye; Leonard Kritharides; Wendy Jessup
Journal:  Circ Res       Date:  2015-01-14       Impact factor: 17.367

4.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

5.  Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease).

Authors:  E J Schaefer; L A Zech; D E Schwartz; H B Brewer
Journal:  Ann Intern Med       Date:  1980-08       Impact factor: 25.391

6.  The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Authors:  Margarita de la Llera-Moya; Denise Drazul-Schrader; Bela F Asztalos; Marina Cuchel; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-14       Impact factor: 8.311

7.  Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro.

Authors:  J A Glomset; K R Norum; W King
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

8.  Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

Authors:  G A Francis; R H Knopp; J F Oram
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Quantification of HDL particle concentration by calibrated ion mobility analysis.

Authors:  Patrick M Hutchins; Graziella E Ronsein; Jeffrey S Monette; Nathalie Pamir; Jake Wimberger; Yi He; G M Anantharamaiah; Daniel Seung Kim; Jane E Ranchalis; Gail P Jarvik; Tomas Vaisar; Jay W Heinecke
Journal:  Clin Chem       Date:  2014-09-15       Impact factor: 8.327

10.  Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma.

Authors:  Rong Huang; R A Gangani D Silva; W Gray Jerome; Anatol Kontush; M John Chapman; Linda K Curtiss; Timothy J Hodges; W Sean Davidson
Journal:  Nat Struct Mol Biol       Date:  2011-03-13       Impact factor: 15.369
View more
  18 in total

Review 1.  Time to ditch HDL-C as a measure of HDL function?

Authors:  Graziella E Ronsein; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

2.  Niacin Therapy Increases High-Density Lipoprotein Particles and Total Cholesterol Efflux Capacity But Not ABCA1-Specific Cholesterol Efflux in Statin-Treated Subjects.

Authors:  Graziella E Ronsein; Patrick M Hutchins; Daniel Isquith; Tomas Vaisar; Xue-Qiao Zhao; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-12-17       Impact factor: 8.311

Review 3.  ABCA1 agonist peptides for the treatment of disease.

Authors:  John K Bielicki
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

4.  Sex steroids mediate discrete effects on HDL cholesterol efflux capacity and particle concentration in healthy men.

Authors:  Katya B Rubinow; Tomas Vaisar; Jing H Chao; Jay W Heinecke; Stephanie T Page
Journal:  J Clin Lipidol       Date:  2018-04-30       Impact factor: 4.766

5.  Chronic marijuana use moderates the correlations of serum cholesterol with systemic mitochondrial function and fluid cognition.

Authors:  Jun Panee; Viola Pomozi; Adrian A Franke; Olivier Le Saux; Mariana Gerschenson
Journal:  Mitochondrion       Date:  2020-03-10       Impact factor: 4.160

Review 6.  Hematopoiesis is regulated by cholesterol efflux pathways and lipid rafts: connections with cardiovascular diseases.

Authors:  Pooranee K Morgan; Longhou Fang; Graeme I Lancaster; Andrew J Murphy
Journal:  J Lipid Res       Date:  2019-08-30       Impact factor: 5.922

7.  Perimenopausal transdermal estradiol replacement reduces serum HDL cholesterol efflux capacity but improves cardiovascular risk factors.

Authors:  Tomas Vaisar; Jennifer L Gordon; Jake Wimberger; Jay W Heinecke; Alan L Hinderliter; David R Rubinow; Susan S Girdler; Katya B Rubinow
Journal:  J Clin Lipidol       Date:  2020-11-24       Impact factor: 4.766

8.  Low CETP activity and unique composition of large VLDL and small HDL in women giving birth to small-for-gestational age infants.

Authors:  Marie Cecilie Paasche Roland; Kristin Godang; Pål Aukrust; Tore Henriksen; Tove Lekva
Journal:  Sci Rep       Date:  2021-03-18       Impact factor: 4.379

9.  The C-565T Polymorphism (rs2422493) of the ATP-binding Cassette Transporter A1 Gene Contributes to the Development and Severity of Coronary Artery Disease in an Iranian Population.

Authors:  Khalil Mahmoodi; Koorosh Kamali; Habib Ghaznavi; Mohammad Soleiman Soltanpour
Journal:  Oman Med J       Date:  2018-07

10.  Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins.

Authors:  Wei-Ming Chen; Wayne H-H Sheu; Pei-Chi Tseng; Tzong-Shyuan Lee; Wen-Jane Lee; Pey-Jium Chang; An-Na Chiang
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.